As of November 2024 BridgeBio Pharma has a market cap of $5.09 Billion USD. This makes BridgeBio Pharma the world's 2739th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 9th, 2024 the market cap of BridgeBio Pharma was reported to be: